Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oosting

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Journal of Animal Science|September 19, 2013
Special topics--Mitigation of methane and nitrous oxide emissions from animal operations: III. A review of animal management mitigation optionsA N Hristov, T Ott, J Tricarico, et al.
The Journal of Pathology|May 2, 2007
Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomasE H Lips, E J de Graaf, R A E M Tollenaar, et al.
Journal of Clinical Pathology|August 29, 2000
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individualsF ter Borg, F J ten Kate, H T Cuypers, et al.
Lancet (London, England)|July 8, 1998
Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigenF ter Borg, F J ten Kate, H T Cuypers, et al.
The Journal of Pathology|May 29, 2008
High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomasA Middeldorp, M van Puijenbroek, M Nielsen, et al.
Allergy|April 18, 2020
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registryLotte S Spekhorst, Lieneke F M Ariëns, Jorien van der Schaft, et al.
Journal of the American Academy of Dermatology|September 18, 2020
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Lotte S Spekhorst, et al.
JAMA Network Open|March 7, 2024
Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic ReviewJulia M T Colombijn, Demy L Idema, Sanne van Beem, et al.
Plos One|January 24, 2022
Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up careSven van Egmond, Ella D van Vliet, Marlies Wakkee, et al.
The British Journal of Dermatology|May 13, 2023
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registryLotte S Spekhorst, Celeste M Boesjes, Laura Loman, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Journal of Animal Science|September 19, 2013
Special topics--Mitigation of methane and nitrous oxide emissions from animal operations: III. A review of animal management mitigation optionsA N Hristov, T Ott, J Tricarico, et al.
The Journal of Pathology|May 2, 2007
Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomasE H Lips, E J de Graaf, R A E M Tollenaar, et al.
Journal of Clinical Pathology|August 29, 2000
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individualsF ter Borg, F J ten Kate, H T Cuypers, et al.
Lancet (London, England)|July 8, 1998
Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigenF ter Borg, F J ten Kate, H T Cuypers, et al.
The Journal of Pathology|May 29, 2008
High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomasA Middeldorp, M van Puijenbroek, M Nielsen, et al.
Allergy|April 18, 2020
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registryLotte S Spekhorst, Lieneke F M Ariëns, Jorien van der Schaft, et al.
Journal of the American Academy of Dermatology|September 18, 2020
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registryLieneke F M Ariëns, Jorien van der Schaft, Lotte S Spekhorst, et al.
JAMA Network Open|March 7, 2024
Representation of Patients With Chronic Kidney Disease in Clinical Trials of Cardiovascular Disease Medications: A Systematic ReviewJulia M T Colombijn, Demy L Idema, Sanne van Beem, et al.
Plos One|January 24, 2022
Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up careSven van Egmond, Ella D van Vliet, Marlies Wakkee, et al.
The British Journal of Dermatology|May 13, 2023
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registryLotte S Spekhorst, Celeste M Boesjes, Laura Loman, et al.
Pageof 16